| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928939 | American Heart Journal | 2012 | 9 Pages |
Abstract
The FREEDOM trial has successfully recruited a high-risk diabetic MVD cohort. Follow-up efforts include aggressive monitoring to optimize background risk factor control. FREEDOM will contribute significantly to the PCI versus CABG debate in diabetic patients with MVD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sameer MD, MS, Michael E. MD, MSc, Whady MD, May Ogdie, George MD, PhD, Alexandra J. MD, David J. MD, MSc, Elizabeth A. ScD, Krishnan MB, ChB, Jean-Francois MD, Victoria Muratov, Lynn A. ScD, Michael MD, Michel E. MD, Valentin MD, PhD,